EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Key Role and Translational Challenges of Lipid-Based Nanomedicine for Effective Prostate Cancer Therapy

Sara Mehri, Mostafa Shourian, Amir Hossein Kheirkhah, Nasim Reihani

International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-25

DOI: 10.2147/ijn.s642461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Sara Mehri und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mehri, S., Shourian, M., Kheirkhah, A. H., & Reihani, N. (2026). Key Role and Translational Challenges of Lipid-Based Nanomedicine for Effective Prostate Cancer Therapy. International Journal of Nanomedicine, Volume 21, 1-25. https://doi.org/10.2147/ijn.s642461

Vancouver

Mehri S, Shourian M, Kheirkhah AH, Reihani N. Key Role and Translational Challenges of Lipid-Based Nanomedicine for Effective Prostate Cancer Therapy. International Journal of Nanomedicine. 2026;Volume 21:1-25. doi:10.2147/ijn.s642461

BibTeX
@article{Mehri2026,
  author = {Mehri, Sara and Shourian, Mostafa and Kheirkhah, Amir Hossein and Reihani, Nasim},
  title = {Key Role and Translational Challenges of Lipid-Based Nanomedicine for Effective Prostate Cancer Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--25},
  doi = {10.2147/ijn.s642461}
}
Kostenlos starten →